Skip to main content

Parallel Advisors, LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in APLS

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,893
+11.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,893
2025-12-31 1,692
2025-09-30 1,970
2025-06-30 1,924
2025-03-31 1,069
2024-12-31 737
2024-09-30 1,879
2024-06-30 1,629
2024-03-31 1,541
2023-12-31 1,497
2023-09-30 1,426
2023-06-30 956
2023-03-31 942
2022-12-31 74
2022-09-30 81
2022-06-30 74
2022-03-31 130
2021-12-31 132
2021-09-30 59
2021-06-30 59
2021-03-31 59
2020-12-31 59
2020-09-30 110
2020-06-30 155